Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial
- PMID: 19796051
- DOI: 10.1111/j.1743-6109.2009.01514.x
Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial
Abstract
Introduction: Erectile dysfunction (ED) has been associated with several comorbidities and can cause significant loss of quality of life and self-esteem.
Aim: In men with ED, to use the validated Self-Esteem and Relationship (SEAR) questionnaire to evaluate changes in self-esteem associated with sildenafil treatment of ED and to assess changes dependent on concomitant comorbid conditions.
Methods: This was a 14-week, international, randomized, parallel-group, double-blind, flexible-dose (25, 50, or 100 mg), placebo-controlled study of sildenafil in men aged >or=18 years with a clinical diagnosis of ED (score <or= 21 on the Sexual Health Inventory for Men).
Main outcome measures: The primary outcome was the change in the SEAR Self-Esteem subscale score from baseline to the end of treatment. Secondary outcomes were the change in SEAR component scores stratified by ED comorbidity, the change in the International Index of Erectile Function (IIEF) domain scores and in the intercourse success rate, and the response to the global efficacy assessment and to the global satisfaction assessment.
Results: A total of 841 patients were included in the intent-to-treat efficacy analysis (559 sildenafil, 282 placebo). Patients randomized to sildenafil had significantly greater change scores from baseline to the end of treatment on all components of the SEAR and all domains of the IIEF (P < 0.0001) compared with placebo. This finding was also consistent for all SEAR components when stratified by each ED comorbidity. In the sildenafil group, the improvement in the mean Self-Esteem subscale score correlated with improvements in the mean Erectile Function domain score (r = 0.6338, P < 0.0001).
Conclusions: The physiologic and emotional benefits of sildenafil in the treatment of ED were confirmed, overall and in men with comorbid hypertension, hyperlipidemia, benign prostatic hypertrophy, and/or depression. Using both the IIEF and the SEAR questionnaires provides a more complete assessment of ED.
Similar articles
-
Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension.J Sex Med. 2008 Aug;5(8):1955-64. doi: 10.1111/j.1743-6109.2008.00879.x. Epub 2008 Jun 28. J Sex Med. 2008. PMID: 18564150 Clinical Trial.
-
Self-esteem, confidence and relationship satisfaction of men with erectile dysfunction treated with sildenafil citrate: a multicenter, randomized, parallel group, double-blind, placebo controlled study in the United States.J Urol. 2006 Mar;175(3 Pt 1):1058-62. doi: 10.1016/S0022-5347(05)00418-0. J Urol. 2006. PMID: 16469617 Clinical Trial.
-
Cumulative response curves to enhance interpretation of treatment differences on the Self-Esteem And Relationship questionnaire for men with erectile dysfunction.BJU Int. 2013 Mar;111(3 Pt B):E115-20. doi: 10.1111/j.1464-410X.2012.11489.x. Epub 2012 Sep 27. BJU Int. 2013. PMID: 23017067
-
Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).Urology. 2006 Sep;68(3 Suppl):26-37. doi: 10.1016/j.urology.2006.06.027. Urology. 2006. PMID: 17011373 Review.
-
Correlations between increased erection hardness and improvements in emotional well-being and satisfaction outcomes in men treated with sildenafil citrate for erectile dysfunction.Int J Impot Res. 2007 Jul-Aug;19(4):398-406. doi: 10.1038/sj.ijir.3901549. Epub 2007 Mar 15. Int J Impot Res. 2007. PMID: 17361232 Review.
Cited by
-
Associations Between Altered Cerebral Activity Patterns and Psychosocial Disorders in Patients With Psychogenic Erectile Dysfunction: A Mediation Analysis of fMRI.Front Psychiatry. 2020 Oct 27;11:583619. doi: 10.3389/fpsyt.2020.583619. eCollection 2020. Front Psychiatry. 2020. PMID: 33192729 Free PMC article.
-
Data on the utilization of treatment modalities for ED in Taiwan in the era of PDE5 inhibitors.Int J Impot Res. 2014 Jul-Aug;26(4):141-5. doi: 10.1038/ijir.2013.53. Epub 2014 Jan 23. Int J Impot Res. 2014. PMID: 24451166
-
Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials: A Systematic Review and Meta-analysis.JAMA Netw Open. 2020 Mar 2;3(3):e201423. doi: 10.1001/jamanetworkopen.2020.1423. JAMA Netw Open. 2020. PMID: 32196105 Free PMC article.
-
Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment.Int J Hypertens. 2012;2012:627278. doi: 10.1155/2012/627278. Epub 2012 May 9. Int J Hypertens. 2012. PMID: 22649713 Free PMC article.
-
Sexual quality of life, body image distress, and psychosocial outcomes in colorectal cancer: a longitudinal study.Support Care Cancer. 2018 Oct;26(10):3431-3440. doi: 10.1007/s00520-018-4204-3. Epub 2018 Apr 20. Support Care Cancer. 2018. PMID: 29679138 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical